STOCK TITAN

Abcam - ABCM STOCK NEWS

Welcome to our dedicated news page for Abcam (Ticker: ABCM), a resource for investors and traders seeking the latest updates and insights on Abcam.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Abcam's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Abcam's position in the market.

News
Rhea-AI Summary
Danaher Corporation (NYSE:DHR) has completed the acquisition of Abcam plc (NASDAQ:ABCM) for $24.00 per share in cash, making Abcam an indirect wholly owned subsidiary of Danaher. Trading of Abcam ADSs on Nasdaq has been suspended.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
acquisition
-
News
Rhea-AI Summary
Danaher Corporation (NYSE:DHR) has completed the acquisition of Abcam plc (NASDAQ:ABCM) for $24.00 per share in cash, making Abcam an indirect wholly owned subsidiary of Danaher. Trading of Abcam ADSs on Nasdaq has been suspended.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.6%
Tags
acquisition
-
Rhea-AI Summary
Abcam plc (Nasdaq: ABCM) has entered into a definitive agreement for its proposed acquisition by Danaher Corporation (NYSE: DHR) for $24.00 per share in cash. The Court has issued the Court Order sanctioning the Scheme, and the Transaction is expected to close on December 6, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.04%
Tags
acquisition
Rhea-AI Summary
Abcam plc (Nasdaq: ABCM) has entered into a definitive agreement for its proposed acquisition by Danaher Corporation (NYSE: DHR) for $24.00 per share in cash. The Court has issued the Court Order sanctioning the Scheme, and the Transaction is expected to close on December 6, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.21%
Tags
acquisition
-
Rhea-AI Summary
Abcam plc (Nasdaq: ABCM) has obtained all Identified Clearances required for its proposed acquisition by Danaher Corporation (NYSE: DHR) for $24.00 per share in cash. The Transaction remains subject to the sanction of the Scheme by the High Court of Justice of England and Wales and the satisfaction or waiver of certain other customary closing conditions. The Court Hearing to sanction the Scheme is scheduled to be held on December 4, 2023. An updated expected timetable of principal events is provided.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.73%
Tags
acquisition
-
Rhea-AI Summary
Abcam plc (Nasdaq: ABCM) has obtained all Identified Clearances required for its proposed acquisition by Danaher Corporation (NYSE: DHR) for $24.00 per share in cash. The Transaction remains subject to the sanction of the Scheme by the High Court of Justice of England and Wales and the satisfaction or waiver of certain other customary closing conditions. The Court Hearing to sanction the Scheme is scheduled to be held on December 4, 2023. An updated expected timetable of principal events is provided.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.64%
Tags
acquisition
Rhea-AI Summary
Abcam shareholders have approved the proposed acquisition by Danaher Corporation. The transaction will involve Danaher acquiring all outstanding shares of Abcam for $24.00 per share in cash. The approval paves the way for a successful transition and the delivery of maximum value to shareholders, employees, and customers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.34%
Tags
acquisition
-
Rhea-AI Summary
Abcam shareholders have approved the proposed acquisition by Danaher Corporation. The transaction will involve Danaher acquiring all outstanding shares of Abcam for $24.00 per share in cash. The approval paves the way for a successful transition and the delivery of maximum value to shareholders, employees, and customers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.4%
Tags
acquisition
-
Rhea-AI Summary
ISS supports Abcam's board recommendation to vote 'FOR' Danaher's proposed acquisition
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.39%
Tags
acquisition
Rhea-AI Summary
Abcam files investor presentation and letter to shareholders regarding proposed sale to Danaher Corporation
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.88%
Tags
none
Abcam

NYSE:ABCM

ABCM Rankings

ABCM Stock Data

5.52B
192.43M
6.44%
88.22%
2.43%
Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Link
United Kingdom
Cambridge

About ABCM

Abcam is a producer, distributor and seller of protein research tools.